Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Watch: Three Cosmetics-Relevant Areas Targeted For Imminent Policy Development

Executive Summary

The European Commission is committed to completing its review “shortly” of the Cosmetics Regulation in light of endocrine disruptor criteria recently implemented in other sectors. Cosmetics industry stakeholders should also keep an eye out for developments as the Commission evolves its approach to nanomaterials and microplastics.

Advertisement

Related Content

EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling
EU Watch: Next Steps Re Controversial CMR Ban Approach, Fragrance Allergens Labeling
ECHA Requests Stakeholder Input On Microplastic Use; Possible Restrictions To Follow
PCPC Defending Against Indiscriminate Plastic Ingredient Attacks
EU Authorities Raising Nanomaterial Awareness With Cosmetics Inventory, 'Observatory'
EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions

Topics

Advertisement
UsernamePublicRestriction

Register

RS121710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel